Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study
Dobelbower, Michael C., Russo, Suzanne M., Raisch, Kevin P., Seay, Leisa L., Clemons, Lisa K., Suter, Susan, Posey, James, Bonner, James A.Том:
17
Мова:
english
Журнал:
Anti-Cancer Drugs
DOI:
10.1097/01.cad.0000185178.26862.4c
Date:
January, 2006
Файл:
PDF, 104 KB
english, 2006
File converter
Більше результатів пошуку
More benefits 
